*瑞信：內地最新醫保藥品目錄結果符合市場預期 | uSMART

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

uSMART

EN

*瑞信：內地最新醫保藥品目錄結果符合市場預期

阿思達克 12-03 14:24

*瑞信：內地最新醫保藥品目錄結果符合市場預期

诺诚健华-B(09969.HK)

沛嘉医疗-B(09996.HK)

康宁杰瑞制药-B(09966.HK)

翰森制药(03692.HK)

Relevant Stocks

诺诚健华-B(09969.HK)

沛嘉医疗-B(09996.HK)

康宁杰瑞制药-B(09966.HK)

翰森制药(03692.HK)

Contact Us

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSMART-Facebook-Page

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.